The Patient Safety and Experience team at Health Innovation Network has been working with behavioural insights specialists on a ‘nudge’ campaign to positively support front-line health and care staff to prioritise their physical health and emotional wellbeing needs, which has undoubtedly been neglected due to the impact of COVID-19.
How is my relative being cared for during the COVID-19 pandemic? UCLPartners has worked with North London Partners to develop a FAQ leaflet to answer some of the common questions relatives have about family members in a care home during the COVID-19 pandemic.
Earlier this year the Academic Health Science Network (AHSN) commissioned the PHG Foundation to produce a report that presents an evidence review of genomics and genomics-related technologies that will have an impact on the delivery of personalised medicine within two to three years or even sooner given the current pace of change arising from the COVID-19 pandemic.
To help provide support and education around the on-going effects of COVID-19, West Midlands Academic Science Network (WMAHSN) is collaborating with Circle Health Rehabilitation and BMI Healthcare to deliver the Future of Rehabilitation series.
Birmingham spinout Revitope Oncology Inc has announced a research collaboration and licence agreement with leading Chinese biopharmaceutical company Junshi Biosciences to develop precision cancer therapies that harness the body’s immune response to kill cancer cells while leaving healthy body tissues untouched.
SBRI Healthcare are pleased to announce that the next funding competition has launched. Companies and organisations are being invited to bid for funding to develop solutions to challenges in Urgent and Emergency Care.
A new Atrial Fibrillation (AF) digital toolkit has been launched to support those working in AF stroke prevention across the NHS.
Birmingham Symptom specific Obstetric Triage System and the SPACE (Safer Provision and Caring Excellence) Programme have been shortlisted in this year’s HSJ Patient Safety Awards, recognising their outstanding contribution to healthcare.
The amalgamation of Medilink East and West Midlands has been given the seal of approval in a move which will serve the best interests of the life sciences sector in the Midlands. This unification, that sees Medilink East and West Midlands operate under a single group company, Medilink Midlands, was unanimously endorsed, in principle, by the Boards of both organisations in June and is the culmination of a strategic alignment that has been developing over the last 6 years.